Melatonin ameliorates hepatic fibrosis via the melatonin receptor 2-medi-ated upregulation of BMAL1 and anti-oxidative enzymes
- Authors
- Kim, Jea Il; Cheon, Hyae Gyeong
- Issue Date
- Mar-2024
- Publisher
- ELSEVIER
- Keywords
- Melatonin; Liver fibrosis; Hepatic stellate cell; Melatonin receptor 2; Anti -oxidant; BMAL1
- Citation
- EUROPEAN JOURNAL OF PHARMACOLOGY, v.966
- Journal Title
- EUROPEAN JOURNAL OF PHARMACOLOGY
- Volume
- 966
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90744
- DOI
- 10.1016/j.ejphar.2024.176337
- ISSN
- 0014-2999
1879-0712
- Abstract
- Hepatic fibrosis, when left untreated, causes serious health problems that progress to cirrhosis and, in some cases, liver cancer. Activation of hepatic stellate cells may be a key characteristic in the development of hepatic fibrosis. Melatonin, a pineal hormone, exerts anti-fibrotic effects; however, the exact mechanisms remain unclear. In this study, the beneficial effects of melatonin against hepatic fibrosis and the underlying mechanisms were investigated using the human hepatic stellate cell line, LX-2, and in vivo murine animal models. The results showed that melatonin suppressed the expression of transforming growth factor (TGF)-beta 1-induced fibrosis markers and production of reactive oxygen species in LX-2 cells. Either 4-phenyl-2-propionamidotetralin, a melatonin receptor 2 selective antagonist, or melatonin receptor 2 small interfering RNA abolished the suppressive effects of melatonin, suggesting the involvement of melatonin receptor 2 in melatonin-induced anti-fibrotic and antioxidative actions. Melatonin increased the expression of the brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (BMAL1), a positive circadian clock gene. BMAL1 knockdown reduced the anti-fibrotic and anti-oxidative effects of melatonin, demonstrating the protective effects of melatonin against TGF-beta 1induced hepatic stellate cell activation by exhibiting melatonin receptor 2-BMAL1-anti-oxidative effects. In highfat diet-induced and carbon tetrachloride-induced hepatic fibrosis models, oral melatonin administration decreased the expression of hepatic fibrosis markers and increased the expression of messenger RNA and levels of proteins of BMAL1 and melatonin receptor 2. Thus, melatonin exerted protective effects against hepatic fibrosis through melatonin receptor 2 activation, followed by an upregulation of the BMAL1-anti-oxidative enzyme pathways.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/90744)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.